Abstract
Summary: In the last few years, the routine development of knockout and transgenic mice and the ease with which rare progenitor populations can be isolated from hematopoietic organs and cultured in vitro has facilitated significant advances in understanding the lineage and development of natural killer (NK) cells. Fluorescence‐activated cell sorter analyses have identified a common lymphoid progenitor capable of giving rise to NK, T, and B cells, confirming the lymphoid origin of NK cells. Knockout and transgenic mouse models have pointed to an absolutely critical role for signals sent through the interleukin (IL)‐2/lS receptor β (CD 122) chain and common γ (γc) chain for NK development. Such signals are likely relayed inside the cell by the tyrosine kinase Jak3, which associates with γc. Recently developed IL‐15 and IL‐15 receptor a knockout mice have pinpointed IL‐15 as the mediator of this signal. Other mouse models have indicated an unexpected role for flt3 ligand in early NK‐cell development as well as minor roles for stem cell factor and IL‐7 in expanding NK‐cell progenitor numbers. Finally, in vitro culture systems have proven useful in identifying the point in NK development at which each of these signals is critical.
References
131
Referenced
105
10.1146/annurev.iy.02.040184.002043
10.1084/jem.186.9.1609
10.1126/science.1439790
10.1016/S1074-7613(00)80269-1
10.1016/S1074-7613(00)80370-2
10.1016/0092-8674(94)90407-3
10.1146/annurev.immunol.15.1.155
10.1073/pnas.91.20.9402
10.1073/pnas.92.16.7545
10.1016/S0092-8674(00)80453-5
10.1016/1074-7613(95)90175-2
10.1016/0092-8674(90)90301-T
10.1016/0092-8674(90)90303-V
10.1016/0092-8674(90)90297-R
10.1016/0092-8674(93)90325-K
10.1038/368643a0
10.1182/blood.V91.4.1101
10.1084/jem.178.3.1079
10.1002/eji.1830270203
10.1073/pnas.91.16.7553
10.1182/blood.V83.9.2594.2594
/ Blood / Differentiation of natural killer (NK) cells from human primitive marrow progenitors in stroma‐based long‐term culture system: identification of a CD34+7+ NK progenitor by Miller JS (1994)10.1182/blood.V85.12.3538.bloodjournal85123538
/ Blood / Lymphokine requirement for (he generation of natural killer cells from CD34+ hematopoietic progenitor cells by Shibuya A (1995)10.1084/jem.184.5.1845
10.1182/blood.V87.7.2632.bloodjournal8772632
10.1182/blood.V88.10.3901.bloodjournal88103901
/ Blood / Role of lL‐2. IL‐7, and IL‐15 in natural killer differentation from cord blood hematopoietic progenitor cells and from γc transduced severe combined immunodeficiency XI bone marrow cells by Cavazzana‐Calvo M (1996)10.1002/j.1460-2075.1990.tb08305.x
{'key': 'e_1_2_1_28_2', 'first-page': '691', 'article-title': "Natural killing by spleen cells from W/W' and Sl/Sld anemic mice", 'volume': '9', 'author': 'Seaman WE', 'year': '1981', 'journal-title': 'Exp Hematol'}
/ Exp Hematol / Natural killing by spleen cells from W/W' and Sl/Sld anemic mice by Seaman WE (1981)10.4049/jimmunol.134.6.3731
/ J Immunol / Origin and differentiation of natural killer cells. I, characteristics of a transplantable NK cell precursor by Hackett J (1985)10.1016/0092-8674(91)90326-T
{'key': 'e_1_2_1_31_2', 'first-page': '1368', 'article-title': 'Expression of flt3 receptor and flt3–ligand in human leukemia‐lymphoma cell lines', 'volume': '9', 'author': 'Meierhoff G', 'year': '1995', 'journal-title': 'Leukemia'}
/ Leukemia / Expression of flt3 receptor and flt3–ligand in human leukemia‐lymphoma cell lines by Meierhoff G (1995){'key': 'e_1_2_1_32_2', 'first-page': '105b', 'article-title': 'The flt3 ligand enhances expansion but not differentiation of human natural killer (NK) cells from CD34+ hematopoetic progenitor cells (HPCs) when combined with interleukin 15 (IL‐IS)', 'volume': '88', 'author': 'Yu H', 'year': '1996', 'journal-title': 'Blood'}
/ Blood / The flt3 ligand enhances expansion but not differentiation of human natural killer (NK) cells from CD34+ hematopoetic progenitor cells (HPCs) when combined with interleukin 15 (IL‐IS) by Yu H (1996){'key': 'e_1_2_1_33_2', 'first-page': '474a', 'article-title': 'Targeted disruption of the flt3 ligand gene in mice affects multiple hematopoietic lineages, including natural killer cells, B lymphocytes, and dendritic cells', 'volume': '88', 'author': 'McKenna HJ', 'year': '1996', 'journal-title': 'Blood'}
/ Blood / Targeted disruption of the flt3 ligand gene in mice affects multiple hematopoietic lineages, including natural killer cells, B lymphocytes, and dendritic cells by McKenna HJ (1996)10.1016/1074-7613(95)90167-1
{'key': 'e_1_2_1_35_2', 'first-page': '3511', 'article-title': 'Antitumor activity and immunotherapeutic properties of flt3–ligand in a murine breast cancer model', 'volume': '57', 'author': 'Chen K', 'year': '1997', 'journal-title': 'Cancer Res'}
/ Cancer Res / Antitumor activity and immunotherapeutic properties of flt3–ligand in a murine breast cancer model by Chen K (1997)10.1038/nm0697-625
10.4049/jimmunol.142.11.3875
/ J Immunol / Normal B cell precursors responsive to recombinant murine IL‐7 and inhibition of IL–7 activity by transforming growth facLor‐β by Lee G (1989)10.1093/intimm/1.5.526
10.1084/jem.181.4.1519
10.4049/jimmunol.157.6.2366
/ J Immunol / Inhibition of γδ T cell development and early thymocyte maturation in IL‐7‐/‐ mice by Moore TA (1996)10.1084/jem.180.5.1955
10.1084/jem.184.1.289
10.1084/jem.171.1.173
10.1084/jem.170.4.1103
10.1182/blood.V84.3.841.841
10.4049/jimmunol.150.12.5263
/ J Immunol / Genesis of human oncolydc natural killer cells from primitive CD34+ CD33‐ bone marrow progenitors by Lotzova E (1993)10.1126/science.8235625
10.1073/pnas.92.2.377
10.1016/1074-7613(95)90047-0
10.1016/0092-8674(93)90167-O
10.1016/1074-7613(95)90066-7
10.1126/science.270.5237.800
10.1126/science.270.5237.794
10.1146/annurev.med.47.1.229
10.1002/jlb.57.5.763
10.1126/science.8178155
10.1002/j.1460-2075.1994.tb06576.x
/ EMBOJ / Utilization of the β and γ chains of the IL‐2 receptor by the novel cytokine IL‐15 by Giri JG (1994)10.1002/j.1460-2075.1995.tb00035.x
10.1084/jem.184.2.325
10.4049/jimmunol.157.10.4282
/ J Immunol / IL‐15 can substitute for the marrow microenvironment in the differentiation of natural killer cells by Puzanov IJ (1996)10.1084/jem.185.3.499
10.1084/jem.180.2.673
10.1084/jem.184.5.2043
10.1016/S1074-7613(00)80443-4
10.1038/35636
10.4049/jimmunol.155.3.1020
/ J Immunol / Natural T cells: cells that co‐express NKRP‐1 and TCR by Bix M (1995)10.4049/jimmunol.147.7.2222
/ J Immunol / A novel monoclonal antibody agains murine IL‐2 receptor p‐chain. Characterization of receptor expression in normal lymphoid cells and El‐4 cells by Tanaka T (1991)10.1016/0167-5699(96)80582-2
10.1073/pnas.89.14.6506
10.1084/jem.180.3.1097
10.1084/jem.179.4.1285
10.1126/science.7907820
10.1126/science.7538697
10.1084/jem.186.2.331
10.1084/jem.180.2.653
10.1084/jem.185.8.1395
10.4049/jimmunol.159.12.5931
/ J Immunol / Role for IL‐15/IL‐15 receptor β‐chain in natural killer 1.1 + T cell receptor‐αβ+ cell development by Ohteki T (1997)10.4049/jimmunol.120.6.1849
/ J Immunol / Spontaneous cell‐mediated cytotoxicity in humans: role of interferon and immunoglobulins by Trinchieri G (1978)10.1002/ijc.2910200309
10.1016/0167-5699(90)90097-S
10.1126/science.7716543
10.1016/1074-7613(95)90025-X
10.4049/jimmunol.155.5.2306
/ J Immunol / Molecular cloning of NKB1: a natural killer cell receptor for HLA‐B allotypes by D'Andrea A (1995)10.4049/jimmunol.142.5.1727
/ J Immunol / Molecular cloning and characterization of a novel murine T cell surface antigen, YE1/48 by Chan P‐Y (1989)10.4049/jimmunol.153.3.1068
/ J Immunol / Ly‐49 multigene family expressed by IL‐2–activated NK cells by Smith HR (1994)10.1111/j.1600-065X.1997.tb00952.x
10.1111/j.1600-065X.1997.tb00941.x
10.1084/jem.185.4.673
10.1016/S1074-7613(00)80441-0
10.1084/jem.156.4.1222
10.1128/iai.41.3.992-997.1983
/ Infect Immun / Interleukin 2 enhances natural killer cell activity through induction of γ interferon by Weigent DA (1983)10.1146/annurev.iy.13.040195.001343
10.1038/378088a0
10.4049/jimmunol.156.11.4274
/ J Immunol / Cloning of the cDNA for human IFN‐γ inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein by Ushio S (1996)10.1126/science.8456300
10.1016/S1074-7613(00)80413-6
/ Immunity / IL‐12–deficient mice are defective in IFNγ production and type 1 cytokine responses by Magram J (1996)10.1016/S1074-7613(00)80543-9
10.1073/pnas.92.16.7307
10.1084/jem.181.5.1755
10.1038/382174a0
10.1038/382171a0
10.1084/jem.170.1.73
10.1146/annurev.iy.09.040191.002325
10.1016/0092-8674(92)90125-V
10.1016/0092-8674(94)90115-5
10.1084/jem.186.12.1957
10.1084/jem.184.5.1725
10.1016/0008-8749(89)90190-1
{'key': 'e_1_2_1_109_2', 'first-page': '2006', 'article-title': 'Hugo P Thymic shared antigen‐1. A novel thymocyte marker discriminating immature from mature thymocyte subsets', 'volume': '148', 'author': 'Godfrey Dl', 'year': '1992', 'journal-title': 'J Imnumol'}
/ J Imnumol / Hugo P Thymic shared antigen‐1. A novel thymocyte marker discriminating immature from mature thymocyte subsets by Godfrey Dl (1992)10.1182/blood.V84.1.111.111
/ Blood / Thymic stem cells in mouse bone marrcjw by Antica M (1994)10.1182/blood.V86.5.1850.bloodjournal8651850
/ Blood / T‐cell lineage commitment and cytokine responses of thymic progenitors by Moore TA (1995){'key': 'e_1_2_1_112_2', 'first-page': '1012', 'article-title': 'Flt3–ligand production by human bone marrow stromal cells', 'volume': '10', 'author': 'Lisovsky M', 'year': '1996', 'journal-title': 'Leukemia'}
/ Leukemia / Flt3–ligand production by human bone marrow stromal cells by Lisovsky M (1996)10.1084/jem.181.4.1357
10.1182/blood.V90.10.3903
/ Blood / Flt 3 ligand enhances the yield of primitive cells after ex vivo cultivation of CD3 4+ CD3 8dim cells and CD34+ CD38dm CD33dim HLA‐DR+ cells by Dooley DC (1997){'key': 'e_1_2_1_115_2', 'volume-title': 'NK cells and cancer: biology and therapy', 'author': 'Williams NS'}
/ NK cells and cancer: biology and therapy by Williams NS10.4049/jimmunol.151.1.60
/ J Immunol / A novel function‐associated molecule related to non‐MHC‐restricted cytotoxicity mediated by activated natural killer cells and T cells by Garni‐Wagner BA (1993)10.1038/358066a0
10.1111/j.1600-065X.1997.tb00940.x
10.1111/j.1600-065X.1997.tb00936.x
10.1111/j.1600-065X.1997.tb00938.x
10.1002/eji.1830271204
10.1002/eji.1830250904
10.1084/jem.173.4.1017
10.4049/jimmunol.157.11.4741
10.1084/jem.185.4.795
10.1002/eji.1830270230
10.4049/jimmunol.157.7.2804
/ J Immunol / Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses by Brumbaugh KM (1996)10.1111/j.1600-065X.1997.tb00949.x
10.1016/S1074-7613(00)80492-6
10.1002/eji.1830261032
10.1038/35869
10.1084/jem.187.5.813
Dates
Type | When |
---|---|
Created | 19 years, 4 months ago (April 30, 2006, 12:56 a.m.) |
Deposited | 1 year, 10 months ago (Oct. 28, 2023, 2:56 a.m.) |
Indexed | 1 week, 6 days ago (Aug. 23, 2025, 1:02 a.m.) |
Issued | 26 years, 11 months ago (Oct. 1, 1998) |
Published | 26 years, 11 months ago (Oct. 1, 1998) |
Published Online | 19 years, 4 months ago (April 28, 2006) |
Published Print | 26 years, 11 months ago (Oct. 1, 1998) |
@article{Williams_1998, title={Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems}, volume={165}, ISSN={1600-065X}, url={http://dx.doi.org/10.1111/j.1600-065x.1998.tb01229.x}, DOI={10.1111/j.1600-065x.1998.tb01229.x}, number={1}, journal={Immunological Reviews}, publisher={Wiley}, author={Williams, Noelle Sevilir and Klem, Jennifer and Puzanov, Igor J. and Sivakumar, P. V. and Schatzle, John D. and Bennett, Michael and Kumar, Vinay}, year={1998}, month=oct, pages={47–61} }